The Aftermath of Intensive Care Delirium. A one-year follow-up focusing on mortality, health-related quality of life, cognitive function and patient experiences.
Delirium is a serious and common condition in the intensive care unit (ICU), which affects 30-50 % of the patients and is associated with increased mortality and morbidity in the context of long-term outcomes. No evidence-based treatment for delirium exists, and currently, delirium is mainly treated pharmacologically with haloperidol, a typical antipsychotic agent. The “Agents Intervening against
